Why Labcorp Holdings (LH) Stock Is Up Today

Labcorp Holdings (LH) is up 3.6% today. Here is some analysis on what might have caused this price movement. ([labcorp.gcs-web.com](https://labcorp.gcs-web.com/?utm_source=openai))

Analysis: The move appears tied to growing optimism ahead of Labcorp’s second-quarter 2026 report on July 30, especially after the company posted a strong first quarter and raised its full-year outlook earlier this year. Recent product launches, a fresh dividend declaration, and mid-July bullish analyst target updates may also be helping sentiment. ([labcorp.com](https://www.labcorp.com/education-events/press-releases/labcorp-announce-second-quarter-2026-financial-results-july-30?utm_source=openai))

Details:

Labcorp said it will release second-quarter 2026 financial results before the market opens on July 30, 2026, putting the stock in focus ahead of earnings. ([labcorp.com](https://www.labcorp.com/education-events/press-releases/labcorp-announce-second-quarter-2026-financial-results-july-30?utm_source=openai))

In first-quarter 2026, revenue rose 5.8% to $3.54 billion, adjusted EPS increased 10.6% to $4.25, and management lifted full-year 2026 guidance. ([sec.gov](https://www.sec.gov/Archives/edgar/data/920148/000092014826000135/form8-kexhibit9911q26.htm))

The updated 2026 outlook calls for enterprise revenue of $14.65 billion to $14.80 billion and adjusted EPS of $17.70 to $18.35, reinforcing expectations for continued growth. ([sec.gov](https://www.sec.gov/Archives/edgar/data/920148/000092014826000135/form8-kexhibit9911q26.htm))

Labcorp also announced nationwide availability of ColoSense in June, declared a $0.72 quarterly dividend in July, and market-tracking analyst pages show fresh July 13 bullish target activity. ([ir.labcorp.com](https://ir.labcorp.com/node/38701/pdf?utm_source=openai))

Sources:

SEC, Labcorp, Benzinga ([sec.gov](https://www.sec.gov/Archives/edgar/data/920148/000092014826000135/form8-kexhibit9911q26.htm))

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$LH Insider Trading Activity

$LH insiders have traded $LH stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.

Here’s a breakdown of recent trading of $LH stock by insiders over the last 6 months:

ADAM H SCHECHTER (President & CEO) has made 0 purchases and 3 sales selling 19,881 shares for an estimated $5,438,896.
PETER J WILKINSON (SVP, Chief Accounting Officer) has made 0 purchases and 2 sales selling 2,299 shares for an estimated $621,200.
BRIAN J CAVENEY (EVP, Pres of ED, CMO & CSO) sold 1,500 shares for an estimated $429,457
JONATHAN C MELTZER (EVP, Operations) has made 0 purchases and 4 sales selling 1,105 shares for an estimated $298,756.
KATHRYN W KYLE (EVP, Chief Legal Officer) has made 0 purchases and 2 sales selling 854 shares for an estimated $227,413.
DER VAART SANDRA D VAN (EVP, Corporate Affairs) sold 547 shares for an estimated $155,999
BRYAN T VAUGHN (EVP and President, Diagnostics) sold 234 shares for an estimated $66,968

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive LH Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$LH Hedge Fund Activity

We have seen 380 institutional investors add shares of $LH stock to their portfolio, and 451 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

WELLINGTON MANAGEMENT GROUP LLP removed 1,003,962 shares (-51.1%) from their portfolio in Q1 2026, for an estimated $267,867,101
DIAMOND HILL CAPITAL MANAGEMENT INC removed 495,846 shares (-39.3%) from their portfolio in Q1 2026, for an estimated $132,296,671
BOSTON PARTNERS added 455,101 shares (+23.8%) to their portfolio in Q1 2026, for an estimated $121,425,497
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC added 374,664 shares (+101.6%) to their portfolio in Q1 2026, for an estimated $99,964,101
JONES FINANCIAL COMPANIES LLLP added 360,032 shares (+5621.1%) to their portfolio in Q1 2026, for an estimated $96,060,137
POINT72 ASSET MANAGEMENT, L.P. added 259,566 shares (+inf%) to their portfolio in Q1 2026, for an estimated $69,254,804
GOLDMAN SACHS GROUP INC removed 199,465 shares (-33.5%) from their portfolio in Q1 2026, for an estimated $53,219,256

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$LH Congressional Stock Trading

Members of Congress have traded $LH stock 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $LH stock by members of Congress over the last 6 months:

SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.
REPRESENTATIVE APRIL MCCLAIN DELANEY has traded it 3 times. They made 3 purchases worth up to $45,000 on 02/11, 02/04, 01/28 and 0 sales.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$LH Price Targets

Multiple analysts have issued price targets for $LH recently. We have seen 4 analysts offer price targets for $LH in the last 6 months, with a median target of $313.0.

Here are some recent targets:

Elizabeth Anderson from Evercore ISI Group set a target price of $300.0 on 04/08/2026
David Westenberg from Piper Sandler set a target price of $300.0 on 02/24/2026
Eric Coldwell from Baird set a target price of $326.0 on 02/18/2026
Lisa Gill from JP Morgan set a target price of $330.0 on 02/18/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.